Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study
Authors:
Open Access
- 31 October 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205897
Abstract
Adults and older people with intellectual disabilities (ID) frequently receive anti-cholinergic drugs in chronic use, but no studies in Italy to date have investigated cumulative anticholinergic exposure and factors associated with high anticholinergic burden in this frail population. To probe the cumulative exposure to anticholinergics and the demographic, social and clinical factors associated with high exposure. The 2012 updated version of the Anticholinergic Burden Score (ACB) was calculated for a multicentre sample of 276 adult and older people over 40 years with ID and associations with factors assessed. Overall, antipsychotics, antiepileptics, anxiolytics, and antidepressants were the most frequent classes contributing to the total ACB score. People living in residential care were more likely exposed to high anticholinergic burden (an ACB score of 3+): both community housing (odds ratio [OR] 4.63, 95%CI 1.08–19.95) and nursing home facility ([OR] 9.99, 95%CI 2.32–43.04). There was also a significant association between an ACB score of 3+ and reporting mental health conditions ([OR] 25.56, 95% CI 8.08–80.89) or a neurological disease ([OR] 4.14, 95%CI 1.32–12.94). Neither demographic characteristics (age and gender) nor other clinical conditions (somatic comorbidity, levels and typology of ID) were associated with higher anticholinergic load. A high burden of anticholinergic was significantly more frequent in laxative users (22.6% ACB3+ vs. 5.1% ACB 0) (p = 0.003). Psychotropics drugs were the highest contributors to the anticholinergic burden in adult and old age ID, especially in those people living in institutional settings with mental health and/or neurological conditions. High anticholinergic load has shown to be associated with the use of laxatives.Keywords
This publication has 49 references indexed in Scilit:
- Clinical consequences of polypharmacy in elderlyExpert Opinion on Drug Safety, 2013
- The National Task Group on Intellectual Disabilities and Dementia Practices Consensus Recommendations for the Evaluation and Management of Dementia in Adults With Intellectual DisabilitiesMayo Clinic Proceedings, 2013
- Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk ScaleDrugs & Aging, 2012
- Effects of controlled discontinuation of long‐term used antipsychotics for behavioural symptoms in individuals with intellectual disabilityJournal of Intellectual Disability Research, 2012
- Outcomes of Polypharmacy in Nursing Home ResidentsClinics in Geriatric Medicine, 2012
- Institutionalization as a Risk Factor for Inappropriate Drug Use in the Elderly: A Swedish Nationwide Register-Based StudyAnnals of Pharmacotherapy, 2012
- The cholinergic system in aging and neuronal degenerationBehavioural Brain Research, 2011
- Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patientsSeizure: European Journal of Epilepsy, 2011
- Use of anticholinergics and the risk of cognitive impairment in an African American populationNeurology, 2010
- Prevalence and risk factors of constipation in adults with intellectual disability in residential care centers in IsraelResearch in Developmental Disabilities, 2007